Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Karoli, A. Rebrov (Russian Federation). Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 5217

Member's Comments

No comment yet.

Related content which might interest you: Assessment of cardiovascular comorbidity Source: Eur Respir Mon 2013; 59: 28-49 Year: 2013 COPD is associated with an increased risk of peripheral artery disease and mortality Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018 Year: 2018 COPD phenotypes not linked to increased risk of coronary heart disease Source: International Congress 2019 – Comorbidities galore in respiratory patients Year: 2019 Underappreciation of coronary artery disease in patients with COPD Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 Lipid profile in COPD patients with coronary artery disease comorbidity Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 COPD as a risk factor for carotid artery disease (CAD) and low-extremity artery disease (LEAD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 Prevalence and risk factors of elevated pulmonary artery pressures in adults with sickle cell disease Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015 In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Assessment of pulmonary function stratifies global coronary heart disease risk Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients Source: ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020 Year: 2020 OSA and coronary artery disease Source: Sleep and Breathing Conference 2021 Year: 2021